Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
The Journal of Experimental Medicine|November 17, 2010
CD14 is a coreceptor of Toll-like receptors 7 and 9Christoph L Baumann, Irene M Aspalter, Omar Sharif, et al.Blood|September 12, 2022
EVI1 drives leukemogenesis through aberrant ERG activationJohannes Schmoellerl, Inês A M Barbosa, Martina Minnich, et al.Nature Communications|September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemiaJessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.Cell|October 18, 2011
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesisFlorian Grebien, Oliver Hantschel, John Wojcik, et al.Biotechnology Journal|January 25, 2022
Designed SARS-CoV-2 receptor binding domain variants form stable monomersMiriam Klausberger, Nikolaus F Kienzl, Gerhard Stadlmayr, et al.Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The different functions of Stat5 and chromatin alteration through Stat5 proteinsJan-Wilhelm Kornfeld, Florian Grebien, Marc A Kerenyi, et al.Cell Death & Disease|May 28, 2024
A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemiaSophie Edtmayer, Agnieszka Witalisz-Siepracka, Bernhard Zdársky, et al.Cancers|September 30, 2020
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid LeukemiaSagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, et al.Nature Chemical Biology|October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CMLGeorg E Winter, Uwe Rix, Scott M Carlson, et al.Blood Advances|July 5, 2019
STAT3β is a tumor suppressor in acute myeloid leukemiaPetra Aigner, Tatsuaki Mizutani, Jaqueline Horvath, et al.Pageof 8